Contract research organization Icon announced a multi-year collaboration with Anthropic this week to bring Claude’s AI capabilities to clinical trials.To advance Icon’s digital innovation, the company will leverage Anthropic’s Life Sciences research team to build on Icon’s agentic AI platform, Orbis, according to a release. The partnership is designed to improve site intelligence and study planning, powering Icon’s OneSearch and OnePlan tools to improve site selection and study feasibility, expanding Orbis’ predictive intelligence to enable real-time detection of enrollment risks, optimizing trial protocol design and scenario modeling and integrating Icon’s clinical knowledge into client systems. “Far too often, the barrier to getting medicines to patients faster is operational, not scientific. Take study enrollment as an example—it’s one of the biggest bottlenecks in clinical development and causes delays in up to 80% of trials,” said Pip White, head of Ireland, UK and Northern Europe for Anthropic.

Full report : CRO Icon announced a multi-year collaboration with Anthropic this week to bring Claude’s AI capabilities to clinical trials.